Xiaoyu Zhang studied pharmacy and medicinal chemistry at China Pharmaceutical University, where she received her bachelor's degree in 2014. In 2020, she received her doctorate in pharmacology from the Institute of Materia Medica of the Chinese Academy of Medical Sciences. During her doctoral thesis, she focused on the discovery of novel antivirals against arenaviruses.
She came to Germany and started her postdoc at TWINCORE in March 2020, where she is currently working on the identification of genetic factors for severe respiratory syncytial virus infection in children.
Sake S, Zhang X, Rajak M, Urbanek-Quaing M, Carpentier A, Gunesch A, Grethe C, Matthaei A, Rückert J, Galloux M, Larcher T, Le Goffic R, Hontonnou F, Chatterjee A, Johnson K, Morwood K, Rox K, Elgaher W, Huang J, Wetzke M, Hansen G, Fischer N, Eléouët J, Rameix-Welti M, Hirsch A, Herold E, Empting M, Lauber C, Schulz T, Krey T, Haid S, Pietschmann T
Lauber C, Zhang X, Vaas J, Klingler F, Mutz P, Dubin A, Pietschmann T, Roth O, Neuman B, Gorbalenya A, Bartenschlager R, Seitz S
Sake S, Kosch C, Blockus S, Haid S, Gunesch A, Zhang X, Friesland M, Trummer S, Grethe C, Kühnel A, Rückert J, Duprex W, Huang J, Rameix-Welti M, Empting M, Fischer N, Hirsch A, Schulz T, Pietschmann T
